FDA.reportPublic FDA data

calcium glycerophosphate 50 MG/ML / calcium lactate 50 MG/ML Oral Suspension

RxCUI
1487296
RxNorm name
calcium glycerophosphate 50 MG/ML / calcium lactate 50 MG/ML Oral Suspension
Term type
SCD
Status
Active
Updated
2026-11-08 10:15:05

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032014
Active start
032014
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
calcium glycerophosphate50 MG / 1 MLcalcium glycerophosphatecalcium glycerophosphate
calcium lactate50 MG / 1 MLcalcium lactatecalcium lactate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Suspension316969

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
calcium glycerophosphate1909
calcium lactate47622

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRcalcium glycerophosphate 50 MG/ML / calcium lactate 50 MG/ML Oral Suspension1NAMES
RxNorm Namecalcium glycerophosphate 50 MG/ML / calcium lactate 50 MG/ML Oral Suspension1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_IDbe118f12-9ced-4b07-8941-a3d1510b4cc01CODES
RxCUI14872961CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
50480013725rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
be118f12-9ced-4b07-8941-a3d1510b4cc0calcium glycerophosphate 50 MG/ML / calcium lactate 50 MG/ML Oral Suspension [SCD]12CAL-PHOS SUSPENSION20140325

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
be118f12-9ced-4b07-8941-a3d1510b4cc0CAL-PHOS SUSPENSIONRadix Laboratories, Inc.20140325

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA12AACalciumATC1-4calcium lactate
MEDRTD017610Calcium CompoundsCHEMhas_ingredientcalcium lactate
MEDRTD005994GlycerophosphatesCHEMhas_ingredientcalcium glycerophosphate
MEDRTD007773LactatesCHEMhas_ingredientcalcium lactate
MEDRTD004342Drug HypersensitivityDISEASEci_withcalcium glycerophosphate
MEDRTD004342Drug HypersensitivityDISEASEci_withcalcium lactate
MEDRTD004942Esophagitis, PepticDISEASEmay_treatcalcium glycerophosphate
MEDRTD006934HypercalcemiaDISEASEci_withcalcium lactate
MEDRTD006934HypercalcemiaDISEASEci_withcalcium glycerophosphate
MEDRTD006996HypocalcemiaDISEASEmay_treatcalcium lactate
MEDRTD006996HypocalcemiaDISEASEmay_treatcalcium glycerophosphate
MEDRTD017674HypophosphatemiaDISEASEci_withcalcium glycerophosphate
MEDRTD017674HypophosphatemiaDISEASEci_withcalcium lactate
MEDRTD007669Kidney CalculiDISEASEci_withcalcium glycerophosphate
MEDRTD007669Kidney CalculiDISEASEci_withcalcium lactate
MEDRTD010024OsteoporosisDISEASEmay_preventcalcium lactate
MEDRTD015663Osteoporosis, PostmenopausalDISEASEmay_treatcalcium glycerophosphate
MEDRTD015663Osteoporosis, PostmenopausalDISEASEmay_treatcalcium lactate
MEDRTN0000000220Electrolyte ActivityMOAhas_moacalcium glycerophosphate
MEDRTN0000000220Electrolyte ActivityMOAhas_moacalcium lactate
MEDRTN0000008312Bone Resorption AlterationPEhas_pecalcium glycerophosphate
MEDRTN0000008312Bone Resorption AlterationPEhas_pecalcium lactate
MEDRTN0000009557Increased Renal PO4-- ExcretionPEhas_pecalcium glycerophosphate
MEDRTN0000009557Increased Renal PO4-- ExcretionPEhas_pecalcium lactate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_VET_DRUGUS
ATTRIBUTESVET_DRUGUS
SOURCESSourceMetathesaurus FDA Structured Product Labels